At a glance
- Originator Novo Nordisk
- Class Small molecules
- Mechanism of Action Protein tyrosine phosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 19 Apr 2002 Preclinical trials in Diabetes mellitus in Denmark (unspecified route)